Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.
D002228:Carbenicillin / Q000494:pharmacology*; D002438:Cefoperazone; D002439:Cefotaxime / Q000031:analogs & derivatives / Q000494:pharmacology; D002441:Cefsulodin; D002442:Ceftazidime; D002443:Ceftriaxone; D002511:Cephalosporins / Q000494:pharmacology*; D002513:Cephamycins / Q000494:pharmacology; D009070:Moxalactam; D010403:Penicillin Resistance; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000201:enzymology; D001618:beta-Lactamases / Q000378:metabolism*
D002511:Cephalosporins; D002513:Cephamycins; D002443:Ceftriaxone; D002438:Cefoperazone; D002442:Ceftazidime; D001618:beta-Lactamases; D002228:Carbenicillin; D002439:Cefotaxime; D002441:Cefsulodin; D009070:Moxalactam